SI1471924T1 - Idraparinuks (sanorg 34006) za zdravljenje in sekundarno profilakso venskih tromboembolicnih profilakso venskih tromboembolicnih dogodkov pri pacientih z globoko vensko trombozo - Google Patents

Idraparinuks (sanorg 34006) za zdravljenje in sekundarno profilakso venskih tromboembolicnih profilakso venskih tromboembolicnih dogodkov pri pacientih z globoko vensko trombozo

Info

Publication number
SI1471924T1
SI1471924T1 SI200330334T SI200330334T SI1471924T1 SI 1471924 T1 SI1471924 T1 SI 1471924T1 SI 200330334 T SI200330334 T SI 200330334T SI 200330334 T SI200330334 T SI 200330334T SI 1471924 T1 SI1471924 T1 SI 1471924T1
Authority
SI
Slovenia
Prior art keywords
venous
thromboemolic
sanorg
idraparinux
events
Prior art date
Application number
SI200330334T
Other languages
English (en)
Inventor
Amsterdam Ronald Gijsbertu Van
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of SI1471924T1 publication Critical patent/SI1471924T1/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024Esters of saccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
SI200330334T 2002-01-29 2003-01-23 Idraparinuks (sanorg 34006) za zdravljenje in sekundarno profilakso venskih tromboembolicnih profilakso venskih tromboembolicnih dogodkov pri pacientih z globoko vensko trombozo SI1471924T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02075374 2002-01-29
PCT/EP2003/000696 WO2003063881A1 (en) 2002-01-29 2003-01-23 Idraparinux(sanorg 34006)for treatment and secondary prophylaxis of venous thromboemolic events in patients with deep venous thrombosis

Publications (1)

Publication Number Publication Date
SI1471924T1 true SI1471924T1 (sl) 2006-10-31

Family

ID=27635850

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200330334T SI1471924T1 (sl) 2002-01-29 2003-01-23 Idraparinuks (sanorg 34006) za zdravljenje in sekundarno profilakso venskih tromboembolicnih profilakso venskih tromboembolicnih dogodkov pri pacientih z globoko vensko trombozo

Country Status (23)

Country Link
US (1) US7709463B2 (sl)
EP (1) EP1471924B1 (sl)
JP (1) JP4870907B2 (sl)
CN (1) CN1622813A (sl)
AR (1) AR038320A1 (sl)
AT (1) ATE323497T1 (sl)
AU (1) AU2003205664B2 (sl)
BR (1) BR0307196A (sl)
CA (1) CA2472957C (sl)
CY (1) CY1107661T1 (sl)
DE (1) DE60304678T2 (sl)
DK (1) DK1471924T3 (sl)
EA (1) EA007204B1 (sl)
ES (1) ES2262971T3 (sl)
HK (1) HK1072361A1 (sl)
MX (1) MXPA04007310A (sl)
NO (1) NO332699B1 (sl)
PE (1) PE20030855A1 (sl)
PL (1) PL207144B1 (sl)
PT (1) PT1471924E (sl)
SI (1) SI1471924T1 (sl)
TW (1) TWI281861B (sl)
WO (1) WO2003063881A1 (sl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0518794A2 (pt) * 2004-12-01 2008-12-09 Osi Pharm Inc composto, composiÇço, mÉtodo de tratamento de distérbio hiperproliferativo, e, biblioteca combinatorial
US9642822B2 (en) 2011-05-27 2017-05-09 Children's Medical Center Corporation Methods for treating and preventing neutrophil-derived net toxicity and thrombosis
WO2021007429A1 (en) 2019-07-09 2021-01-14 Optimvia Llc Methods for synthesizing anticoagulant polysaccharides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378829A (en) * 1990-04-23 1995-01-03 Akzo N.V. Sulfated glycosaminoglycanoid derivatives of the heparin and heparan sulfate type

Also Published As

Publication number Publication date
JP4870907B2 (ja) 2012-02-08
ATE323497T1 (de) 2006-05-15
EP1471924B1 (en) 2006-04-19
PL207144B1 (pl) 2010-11-30
DE60304678D1 (de) 2006-05-24
WO2003063881A1 (en) 2003-08-07
BR0307196A (pt) 2004-11-03
JP2005519919A (ja) 2005-07-07
NO332699B1 (no) 2012-12-10
TWI281861B (en) 2007-06-01
CA2472957C (en) 2011-09-13
ES2262971T3 (es) 2006-12-01
PL370557A1 (en) 2005-05-30
EA200400817A1 (ru) 2005-02-24
DE60304678T2 (de) 2007-04-05
PT1471924E (pt) 2006-09-29
CY1107661T1 (el) 2013-04-18
MXPA04007310A (es) 2004-10-29
US7709463B2 (en) 2010-05-04
AR038320A1 (es) 2005-01-12
TW200302104A (en) 2003-08-01
HK1072361A1 (en) 2005-08-26
CN1622813A (zh) 2005-06-01
PE20030855A1 (es) 2003-10-11
CA2472957A1 (en) 2003-08-07
EA007204B1 (ru) 2006-08-25
AU2003205664B2 (en) 2008-06-05
US20050209175A1 (en) 2005-09-22
DK1471924T3 (da) 2006-08-21
EP1471924A1 (en) 2004-11-03
NO20043195L (no) 2004-10-29

Similar Documents

Publication Publication Date Title
EP1543034A4 (en) TREATMENT AND PROPHYLAXIS WITH 4-1BB BINDING AGENTS
HK1089376A1 (en) Formulation for use in the prevention and treatment of carbohydrate induced ; diseases and conditions
GB0113119D0 (en) Knitted substrate for use in medical bandaging product bandaging product and method of forming the same
AU2002233342A1 (en) Implants with FK506 for prophylaxis and treatment of restonoses
ZA200505272B (en) Treatment of skin wounds using polyenylphosphatidylcholine and alkanolamines
IL157577A0 (en) Disposable underpants and method of providing the same
EP1461024A4 (en) TREATMENT OF WOUNDS AND COMPOSITIONS USED
AU8136801A (en) Methods of preventing or treating diseases and conditions using complex carbohydrates
AU2003209851A1 (en) Method of treatment and/or prophylaxis
EP1416957A4 (en) TREATMENT OF IMMUNE DISEASES AND B-CELL DISEASES
AU5754701A (en) Method of using cox-2 inhibitors in the treatment and prevention of ocular cox-2mediated disorders
AU2003234976A1 (en) The use of the human urinary kininogenase in the manufacture of a medicine for treating and preventing cerebral embolism
AU2003274963A8 (en) Mda-7 and free radicals in the treatment of cancer
SI1471924T1 (sl) Idraparinuks (sanorg 34006) za zdravljenje in sekundarno profilakso venskih tromboembolicnih profilakso venskih tromboembolicnih dogodkov pri pacientih z globoko vensko trombozo
GB0115707D0 (en) Treatment and prevention of lipodermatosclerosis
GB9922752D0 (en) Medical devices and treatment and prophylaxis
IL162941A0 (en) Carboxamidine derivatives and their use in the treatment of vascular diseases
AU6746501A (en) Methods for prevention of ulcers and improving physiological performance
AU2003219880A8 (en) Methods and compounds useful in inhibiting oxidative and/or free radical damage and in the treatment and prevention of disease
EP1284746A4 (en) TREATMENT AND PREVENTION
EP1696918A4 (en) METHOD FOR THE TREATMENT OF HIV INFECTIONS IN PATIENTS WITH ATAZANAVIR RESISTANCE USING A COMBINATION OF ATAZANAVIR AND ANOTHER PROTEASE INHIBITOR
IL161388A0 (en) Method of reducing type 2 diabetes in high risk patients
SG99857A1 (en) A method of treatment and prophylaxis
AU2003225191A8 (en) Methods useful in treatment and prevention of hiv infection
AU2002950957A0 (en) A method of treatment and prophylaxis